Status:
TERMINATED
Selenium Supplementation of Patients With Cirrhosis
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being conducted to determine if patients with cirrhosis (liver disease) are selenium deficient. The effect of supplementation with two chemical forms of selenium on plasma selenium bioma...
Detailed Description
Selenium is an essential nutrient that plays a role in oxidant defense, among other functions. There is much interest in the role selenium may play in several disease processes. It is possible that ce...
Eligibility Criteria
Inclusion
- adults with cirrhosis
Exclusion
- Pregnancy or planning a pregnancy
- Selenium supplements of 25 µg or more within the past year
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00212212
Start Date
March 1 2006
End Date
March 1 2012
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University
Nashville, Tennessee, United States, 37232